Cocrystal Pharma Inc — Financial Statements (NASDAQ:COCP) | MetaTrader

Open full chart

新闻

Cocrystal Pharma advances norovirus drug candidate to Phase 1b trial

Tuesday’s Insider Activity: Major Buys at CBC, COCP; Sells at ARES, RKLB

菲利普·弗罗斯特购入价值18,812美元的Cocrystal Pharma (COCP)股票

Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812

Cocrystal Pharma raises $1.03 million in private placement from directors

Cocrystal Pharma receives $500,000 NIH grant for influenza drug

Cocrystal Pharma完成470万美元的注册直接发行

Cocrystal Pharma closes $4.7 million registered direct offering

Cocrystal Pharma通过定向增发筹集470万美元资金

Cocrystal Pharma raises $4.7 million in registered direct offering

Cocrystal的诺如病毒药物CDI-988进入1b期研究

Cocrystal’s norovirus drug CDI-988 advances to phase 1b study